Ott P, Eriksen P, Kjaergaard K, Sorensen M, Thomsen K, Vilstrup H
Metab Brain Dis. 2024; 40(1):48.
PMID: 39621139
PMC: 11611965.
DOI: 10.1007/s11011-024-01435-3.
Yoon J, Lee J, Yu M, Hur B, Grimm R, Sourbron S
Eur Radiol. 2021; 32(1):34-45.
PMID: 34120229
DOI: 10.1007/s00330-021-08087-2.
Levitt D, Levitt M
Clin Exp Gastroenterol. 2018; 11:193-215.
PMID: 29872332
PMC: 5973424.
DOI: 10.2147/CEG.S160921.
McConnell M, Iwakiri Y
Hepatol Int. 2017; 12(Suppl 1):11-23.
PMID: 29075990
PMC: 7090883.
DOI: 10.1007/s12072-017-9826-x.
Bosch J, Groszmann R, Shah V
J Hepatol. 2015; 62(1 Suppl):S121-30.
PMID: 25920081
PMC: 4519833.
DOI: 10.1016/j.jhep.2015.01.003.
Risk models and scoring systems for predicting the prognosis in critically ill cirrhotic patients with acute kidney injury: a prospective validation study.
Pan H, Jenq C, Tsai M, Fan P, Chang C, Chang M
PLoS One. 2012; 7(12):e51094.
PMID: 23236437
PMC: 3517580.
DOI: 10.1371/journal.pone.0051094.
Alterations in arterial blood parameters in patients with liver cirrhosis and ascites.
Charalabopoulos K, Peschos D, Zoganas L, Bablekos G, Golias C, Charalabopoulos A
Int J Med Sci. 2007; 4(2):94-7.
PMID: 17396160
PMC: 1838824.
DOI: 10.7150/ijms.4.94.
Pharmacokinetics of quinine in chronic liver disease.
Auprayoon P, Sukontason K, Na-Bangchang K, Banmairuroi V, Molunto P, Karbwang J
Br J Clin Pharmacol. 1995; 40(5):494-7.
PMID: 8703656
PMC: 1365198.
DOI: 10.1111/j.1365-2125.1995.tb05795.x.
Effect of portosystemic shunting on PGI2 and glucagon levels in humans.
Sitzmann J, Campbell K, Wu Y, Cameron J
Ann Surg. 1993; 217(3):248-52.
PMID: 8452403
PMC: 1242777.
DOI: 10.1097/00000658-199303000-00006.
Evaluation of portal circulation through the superior mesenteric vein with an enteric capsule of [123I]iodoamphetamine.
Shiomi S, Kuroki T, Miyazawa Y, Ueda T, Takeda T, Nishiguchi S
J Gastroenterol. 1995; 30(1):55-60.
PMID: 7719415
DOI: 10.1007/BF01211375.
Roles of hepatic blood flow and enzyme activity in the kinetics of propranolol and sotalol.
Pirttiaho H, Sotaniemi E, Pelkonen R, Pitkanen U, Anttila M, Sundqvist H
Br J Clin Pharmacol. 1980; 9(4):399-405.
PMID: 7378257
PMC: 1429970.
DOI: 10.1111/j.1365-2125.1980.tb01068.x.
Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver.
Pentikainen P, Neuvonen P, Jostell K
Eur J Clin Pharmacol. 1980; 17(4):275-84.
PMID: 6995129
DOI: 10.1007/BF00625801.
Mesocaval and distal splenorenal shunts: effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathy.
HERZ R, Halbfass H, Rossle M, Waldmann D, Gerok W
Klin Wochenschr. 1985; 63(9):409-18.
PMID: 3873574
DOI: 10.1007/BF01733666.
Treatment of ascites in patients with cirrhosis of the liver.
Arroyo V, Gines P, Rodes J
Intensive Care Med. 1987; 13(3):154-61.
PMID: 3584645
DOI: 10.1007/BF00254698.
Enhanced oral bioavailability of meptazinol in cirrhosis.
Birnie G, Thompson G, Murray T, Watkinson G, Brodie M
Gut. 1987; 28(3):248-54.
PMID: 3570028
PMC: 1432689.
DOI: 10.1136/gut.28.3.248.
Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.
Reichen J, Egger B, Ohara N, Zeltner T, Zysset T, Zimmermann A
J Clin Invest. 1988; 82(6):2069-76.
PMID: 3198765
PMC: 442790.
DOI: 10.1172/JCI113828.
Limitations of percutaneous transhepatic cholangioscopy in the removal of complicated biliary calculi.
Jeng K, CHIANG H, Shih S
World J Surg. 1989; 13(5):603-10.
PMID: 2683403
DOI: 10.1007/BF01658880.
Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.
Sitzmann J, Bulkley G, Mitchell M, Campbell K
Ann Surg. 1989; 209(3):322-7.
PMID: 2493776
PMC: 1493952.
DOI: 10.1097/00000658-198903000-00012.
Evaluation of portal-systemic shunting in rats from mesenteric and splenic beds.
Stauber R, Ruthardt F, TAUXE W, Van Thiel D
Dig Dis Sci. 1991; 36(2):209-15.
PMID: 1988265
DOI: 10.1007/BF01300758.
Clinical pharmacokinetics in patients with liver disease.
McLean A, Morgan D
Clin Pharmacokinet. 1991; 21(1):42-69.
PMID: 1914341
DOI: 10.2165/00003088-199121010-00004.
